Programme - Thursday March 24th - CEST time zone
01:00 - 23:59
WCO-IOF-ESCEO
17:00 - 19:15
WCO-IOF-ESCEO - OPENING CEREMONY
Chairpersons: John A. Kanis and Jean-Yves Reginster
17:00
Best clinical papers published in 2021
17:45
Opening of the meeting
18:00
Importance of musculoskeletal health for Healthy Aging
18:10
Presentation of the 2022 ESCEO-Islene Araujo de Carvalho Grant
18:15
Educational Lecture
Role of Berlin in History
18:45
Presentation of the 2022 ESCEO Medal of Excellence
18:55
Presentation of the IOF Olof Johnell Science Award
19:05
IOF Anthem
19:15 - 20:15
Available Industry Sponsored Welcome Cocktail
Programme - Friday March 25th - CEST time zone
08:00 - 09:00
Available Sponsored Breakfast Satellite Symposium
08:00 - 09:00
Available Sponsored Breakfast Satellite Symposium
08:00 - 09:00
Non-Sponsored Symposium
08:00 - 09:00
ESCEO SYMPOSIUM
Management of patients at very high risk of osteoporotic fractures through sequential treatments
Chairpersons: Cyrus Cooper and John A. Kanis
- Welcome
- How to define patients at very high risk of presenting an osteoporotic fracture
- How to manage patients at very high of presenting an osteoporotic fracture
- Discussion - All members of the Working Group
09:00 - 10:30
Scientific Session I
Chairpersons: René Rizzoli and Cyrus Cooper
09:00
Plenary Lecture 1
Can we expect new chemical entities for the management of osteoporosis in the coming years
09:30
Oral Communication selected from abstracts
10:30 - 12:10
Scientific Session II
Chairpersons: Nicholas Harvey and Bess Dawson-Hughes
10:30
Presentation of the ESCEO-IOF Herbert Fleisch Medal
10:40
Plenary Lecture 2
Update of the management of patients at imminent fracture risk
11:10
Presentation of the IOF President's Award
11:20
Oral communication selected from abstracts
12:15 - 13:45
Available Sponsored Lunch Satellite Symposium
12:15 - 13:45
Available Sponsored Lunch Satellite Symposium
14:00 - 15:00
MEET-THE-EXPERT SESSIONS
14:00
Role of biochemical assessments in the management of osteoporosis
14:00
German guidelines for the management of post-menopausal osteoporosis
14:00
Treatment of disorders of phosphate homeostasis
14:00
Which drugs do impact fracture healing?
14:00
Assessment of quality of life in sarcopenia: an urgent issue
14:00 - 15:00
Poster Viewing Session I
14:00 - 15:10
Oral presentation of selected posters
14:00 - 15:00
Educational Lecture
- Post-fracture care: State of the Art?
15:00 - 17:00
Scientific Session III
Chairpersons: Eugene McCloskey and Friederike Thomasius
15:00
Plenary Lecture 3
Calcium or vitamin D: both or neither?
15:30
Oral communication selected from abstracts
16:30
Plenary Lecture 4
How long should we treat osteoporosis?
15:00 - 16:45
COMMITTEE OF NATIONAL SOCIETIES SPECIAL PLENARY SESSION
Contributions to the fight against the osteoporosis pandemic
Chairpersons: Jean-Yves Reginster and Famida Jiwa
17:00 - 18:30
Available Sponsored Satellite Symposium
17:00 - 18:30
Available Sponsored Satellite Symposium
Programme - Saturday March 26th - CEST time zone
08:00 - 09:00
Non-Sponsored Symposium
08:00 - 09:00
Sponsored Breakfast Satellite Symposium
08:00 - 09:00
Available Sponsored Breakfast Satellite Symposium
08:00 - 09:00
ISGE-ESCEO-IOF Symposium
Connective tissues and bone after the Menopause: how to protect from natural evolutions ?
Chairpersons: Andrea Genazzani and Mark Brincat
- Connective Tissue Changes and Osteoporosis after the Menopause. Similarities in response to Menopause and Various Treatments.
- Hormone Replacement Therapy in post-menopause for bone loss prevention: when, how and for how long
08:00 - 09:00
OARSI-ESCEO Symposium
Osteoporosis and Osteoarthritis re-visited: Are they linked, and if so, how?
Chairpersons: Jean-Yves Reginster and Ali Mobasheri
- Introduction
- Osteoarthritis and osteoporosis: does the epidemiology suggest an inverse or collinear relationship?
- Can we reach a unifying pathophysiologic framework for these two common musculoskeletal disorders?
- Obesity, osteoarthritis and osteoporosis: any evidence for shared pathogenesis?
- Physical activity, OA and osteoporosis: protective or risky?
- Discussion
08:00 - 09:00
EUGMS-ESCEO-IOF Symposium
Assessing frailty to make treatment decisions
Chairperson: Stefania Maggi
- Assessing frailty in patients with musculoskeletal conditions
- Using frailty to tailor complex decisions to patient needs
09:00 - 10:30
Scientific Session IV
Chairpersons: Claudia Campusano and Etienne Cavalier
09:00
Plenary Lecture 5
Added value of the new version of the FRAX® algorithm
09:30
Oral communication selected from abstracts
10:20
Presentation of the ESCEO-IOF Pierre Meunier Young Scientist Award
10:30 - 12:10
Scientific Session V
Chairpersons: Stefania Maggi and Andreas Kurth
10:30
Presentation of the IOF Medal of Achievement
10:40
Plenary Lecture 6
Cross-talking between the immune system and the skeleton
11:10
Oral communication selected from abstracts
12:15 - 13:45
Available Sponsored Lunch Satellite Symposium
12:15 - 13:45
Available Sponsored Lunch Satellite Symposium
14:00 - 15:00
MEET-THE-EXPERT SESSIONS
14:00
Role of registries in musculoskeletal management
14:00
Management of tumoral bone disease
14:00
Assessment and management of primary hyperparathyroidism
14:00
Cardio-vascular effects of bisphosphonates
14:00 - 15:00
Poster Viewing Session II
14:00 - 15:03
Oral presentation of selected posters
14:00 - 15:00
Educational Lecture
- How can artificial intelligence impact the management of musculoskeletal diseases
14:00 - 15:00
ESCEO SYMPOSIUM
Management of hand osteoarthritis: from an US evidence-based medicine guideline to an European patient-centric approach
Chairpersons: Olivier Bruyère and Ali Mobasheri
- Welcome
- Management of hand osteoarthritis: what really matters for the patient
- Management of hand osteoarthritis: how can the ACR guidelines be applied to an European population, in a patient-centric approach?
- Discussion - All participants of the Working Group
15:00 - 17:00
Scientific Session VI
Chairpersons: Olivier Bruyère and Patricia Clark
15:00
Plenary Lecture 7
Skeletal and extraskeletal effects of FGF23
15:30
Oral communication selected from abstracts
16:30
Plenary Lecture 8
How to treat bone fragility in chronic kidney disease
15:00 - 17:10
Committee of Scientific Advisors Special Session
Chairperson: Nicholas Harvey
- Assessing metastatic and non-metastatic fracture risk in patients with cancer: IOF CSA Bone and Cancer Working Group
- Role of bone microstructure in diabetes bone fragility: IOF CSA Bone and Diabetes Working Group
- Can we improve communication of risk to patients? A project from the IOF CSA Epidemiology and Quality of Life Working Group
17:00
Presentation of the IOF Skeletal Rare Disease Academy Awards
17:05
Presentation of the IOF Nutrition Awards
17:00 - 18:30
Available Sponsored Satellite Symposium
17:00 - 18:30
Available Sponsored Satellite Symposium
Programme - Sunday March 27th - CEST time zone
08:00 - 09:00
Non-Sponsored Symposium
08:00 - 09:00
ESPRM-ESCEO joint Symposium
Update in Non pharmacological and Non surgical Approaches in Osteoarthritis
Chairpersons: Fitnat Dincer and Andreas Winkelmann
- Update in Non pharmacological and Non surgical approaches in Hand Osteoarthritis
- Update in Non pharmacological and Non surgical approaches in Knee Osteoarthritis
- Update in Non pharmacological and Non surgical approaches in Hip Osteoarthritis
08:00 - 09:00
SICOT-ESCEO-IOF Symposium
09:00 - 10:00
MEET-THE-EXPERT SESSIONS
09:00
Development of fracture prevention services in low- and middle-income countries
09:00
Management of osteoarthritis in 2022: How to reconciliate divergent guidelines
09:00
Pharmacological and non-pharmacological management of patients following hip fracture
09:00
Fall prevention strategies
09:00
Hormonal contraception and bone health
09:00
The Use of Bisphosphonates to Manage Muscle Wasting
09:00 - 10:00
Poster Viewing Session III
10:00 - 12:00
Scientific Session VII
Chairpersons: Manju Chandran and Emmanuel Biver
10:00
Plenary Lecture 9
Muscle and joint: Sarcopenia and Osteoarthritis
10:30
Oral communication selected from abstracts
11:30
Plenary Lecture 10
Health Economics in osteoporosis : which model for which assessment
12:00 - 13:00
Non-Sponsored Symposium